Abstract:[Objective] To evaluate the clinical value of 18F-FDG PET/CT in the diagnosis of cardiac neoplasm.[Methods] From October 2014 to March 2017,a total of 27 patients diagnosed with cardiac neoplasm underwent whole body 18F-FDG PET/CT imaging were respectively analysised.18F-FDG PET/CT diagnosis was confirmed by either histopathology or the follow-up outcome.Cardiac space-occupying lesions shows increased FDG uptake in the imaging of PET/CT and diagnosed malignance lesions when SUVmax≥5.7.Then compared with histopathology or the follow-up outcome to evaluate the clinical application of 18F-FDG PET/CT imaging in the diagnosis of cardiac neoplasm.Two-sample t test was used for data analysis.[Results] Among 27 cases of cardiac space-occupying lesions,11 cases were malignant tumors,16 cases were benign tumors.The average SUVmax of malignant tumors (n=l 1) was 9.03±4.5,which was significantly higher than that of benign tumors (n=16,3.25±2.51) (t=4.25,P＜0.001).With a cut-off SUVmax ≥ 5.7,18F-FDG PET/CT could be used to diagnose cardiac neoplasm with a sensitivity of 81.8％ (9/11),specificity of 93.8％(15/16),and accuracy of 88.9％(24/27).[Conclusion] The whole body scan of 18F-FDG PET/CT can aid the noninvasive diagnosis of cardiac malignant tumors from benign lesions.

Clinical Application of 18F-FDG PET/CT in Diagnosis of Cardiac Neoplasm